These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22364837)

  • 41. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fluvastatin].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():587-91. PubMed ID: 11347136
    [No Abstract]   [Full Text] [Related]  

  • 44. [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732408
    [No Abstract]   [Full Text] [Related]  

  • 45. A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology.
    Watts GF; van Bockxmeer FM; Bates T; Burnett JR; Juniper A; O'Leary P
    Heart Lung Circ; 2010 Jul; 19(7):419-22. PubMed ID: 20363671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
    MMW Fortschr Med; 2003 May; 145(20):59. PubMed ID: 12822234
    [No Abstract]   [Full Text] [Related]  

  • 47. Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoin.
    Tomlinson B; Chan JC; Chan WB; Chen WW; Chow FC; Li SK; Kong AP; Ma RC; Siu DC; Tan KC; Wong LK; Yeung VT; But BW; Cheung PT; Fu CC; Tung JY; Wong WC; Yau HC
    Hong Kong Med J; 2018 Aug; 24(4):408-415. PubMed ID: 30100583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.
    Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B
    J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little.
    Hovingh GK; Kastelein JJ
    Circulation; 2016 Sep; 134(10):710-2. PubMed ID: 27601557
    [No Abstract]   [Full Text] [Related]  

  • 51. Familial hypercholesterolaemia: new treatment options.
    Ezzahti M; Sijbrands EJ; Mulder MT; Roeters van Lennep JE
    Neth J Med; 2013 Jun; 71(5):227-33. PubMed ID: 23799308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of therapy with simvastatin 80 mg and 120 mg in patients with familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Chik G
    Int J Clin Pract; 2001 Dec; 55(10):673-5. PubMed ID: 11777291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterozygous familial hypercholesterolemia: a new point-mutation (1372del2) in the LDL-receptor gene which causes severe hypercholesterolemia.
    Widhalm K; Iro C; Lindemayr A; Schmidt H; Kostner G
    Hum Mutat; 1999 Oct; 14(4):357. PubMed ID: 10502834
    [No Abstract]   [Full Text] [Related]  

  • 55. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel.
    Al-Ashwal A; Alnouri F; Sabbour H; Al-Mahfouz A; Al-Sayed N; Razzaghy-Azar M; Al-Allaf F; Al-Waili K; Banerjee Y; Genest J; Santos RD; Al-Rasadi K
    Curr Vasc Pharmacol; 2015; 13(6):759-70. PubMed ID: 26311574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypercholesterolaemia and its management.
    Bhatnagar D; Soran H; Durrington PN
    BMJ; 2008 Aug; 337():a993. PubMed ID: 18719012
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.
    Vuorio AF; Kovanen PT; Gylling H
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):405-15. PubMed ID: 15151486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [LDL adsorption for therapy of hyperlipidemia].
    Azuma N
    Nihon Rinsho; 2004 May; 62 Suppl 5():599-602. PubMed ID: 15197992
    [No Abstract]   [Full Text] [Related]  

  • 60. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.